IMPACT OF GENOTYPE ON MAVACAMTEN RESPONSIVENESS IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

被引：0
|
作者：
Giudicessi, John [1 ]
Alsidawi, Said [1 ]
Geske, Jeffrey Benjamin [1 ]
Newman, Darrell Brian [1 ]
Arruda-Olson, Adelaide Maria [1 ]
Bos, Johan Martijn [1 ]
Ommen, Steve R. [1 ]
Ackerman, Michael John [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1504-122
引用
收藏
页码：735 / 735
页数：1
相关论文
共 50 条
  • [1] Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy
    Giudicessi, John R.
    Alsidawi, Said
    Geske, Jeffrey B.
    Newman, Darrell B.
    Arruda-Olson, Adelaide M.
    Bos, j. Martijn
    Ommen, Steve R.
    Ackerman, Michael J.
    MAYO CLINIC PROCEEDINGS, 2024, 99 (02) : 341 - 343
  • [2] Mavacamten for hypertrophic obstructive cardiomyopathy
    Quintana, Eduard
    Bajona, Pietro
    Myers, Patrick O.
    LANCET, 2021, 397 (10272): : 369 - 369
  • [3] Impact of Mavacamten on blood pressure in Hypertrophic Obstructive Cardiomyopathy
    Shehadeh, Mohanad
    Eid, Fahad
    Rahhal, Alaa
    Hanafi, Amir
    Eid, Mohamed
    Baibhav, Bipul
    CIRCULATION, 2024, 150
  • [4] Mavacamten for Obstructive Hypertrophic Cardiomyopathy in China
    Desai, Milind Y.
    JAMA CARDIOLOGY, 2023, 8 (10) : 966 - 967
  • [5] Mavacamten (Camzyos) for Obstructive Hypertrophic Cardiomyopathy
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1652): : 89 - 91
  • [6] Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Rader, Florian
    Oreziak, Artur
    Choudhury, Lubna
    Saberi, Sara
    Fermin, David
    Wheeler, Matthew T.
    Abraham, Theodore P.
    Garcia-Pavia, Pablo
    Zwas, Donna R.
    Masri, Ahmad
    Owens, Anjali
    Hegde, Sheila M.
    Seidler, Tim
    Fox, Shawna
    Balaratnam, Ganesh
    Sehnert, Amy J.
    Olivotto, Iacopo
    JACC-HEART FAILURE, 2024, 12 (01) : 164 - 177
  • [7] Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension
    Wang, Andrew
    Spertus, John A.
    Wojdyla, Daniel M.
    Abraham, Theodore P.
    Nilles, Ester Kim
    Owens, Anjali Tiku
    Saberi, Sara
    Cresci, Sharon
    Sehnert, Amy
    Lakdawala, Neal K.
    JACC-HEART FAILURE, 2024, 12 (03) : 567 - 579
  • [8] MAVACAMTEN USE FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN AN OCTOGENARIAN
    Chandrasekhar, Sanjay Amrith
    Enciso, Juan
    Casals, Luke R.
    Wu, Robby
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2801 - 2801
  • [9] Genotype Analysis of LVOT Gradient Measurements in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy?
    Chandrasekhar, S. A.
    Cornelio, C. K.
    Miranda, A. C.
    Wu, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S504 - S504
  • [10] Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy
    Zampieri, Mattia
    Argiro, Alessia
    Marchi, Alberto
    Berteotti, Martina
    Targetti, Mattia
    Fornaro, Alessandra
    Tomberli, Alessia
    Stefano, Pierluigi
    Marchionni, Niccolo
    Olivotto, Iacopo
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (07)
12345